{
  "meta": {
    "title": "Ca_Breast",
    "url": "https://brainandscalpel.vercel.app/ca-breast-7e7b95b7.html",
    "scrapedAt": "2025-11-30T11:20:47.256Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibroadenoma</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical hyperplasia</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Radial scar</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Papilloma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following carries a slightly increased risk of invasive breast carcinoma based on the pathological examination of benign breast tissue?</span></p>",
      "unique_key": "DT1187202",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187202,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Papilloma carries a slightly increased risk of invasive breast cancer.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510048acd12a9-0311-4882-8c7c-88d3b0f025e6.PNG\">",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Nulliparous women</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Breast feeding</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">First child at a later age</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Early menarche</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following acts as a protective factor against breast carcinoma?</span></p>",
      "unique_key": "DT1187204",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187204,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Protective factors for breast cancer include:</p>\n<ul>\n<li>Breast feeding</li>\n<li>First pregnancy at an early age <strong>(Option B ruled out )</strong></li>\n<li>Late menarche <strong>(Option D ruled out )</strong></li>\n<li>Early menopause</li>\n<li>Multiparity <strong>(Option A ruled out )</strong></li>\n</ul>\n<p>Breast cancer is the most common cause of death in middle-aged women in Western countries.</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Age of patient</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">History of radiation exposure</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Age at first live birth</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Older age at menopause</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a modifiable risk factor for breast carcinoma?</span></p>",
      "unique_key": "DT1187205",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187205,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Age at first live birth </strong>is a modifiable risk factor for breast carcinoma</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025100483830ae6-060f-47c5-89a4-a51b31ef8c4c.PNG\"><br>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;  \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403195662ade5-72a2-4d5d-8325-0db887ba8588.jpg\">",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">BRCA 1</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">BRCA 2</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">PTEN</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">KRAS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following genes is most commonly associated with the development of breast carcinoma?</span></p>",
      "unique_key": "DT1187207",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187207,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<h3><strong>Explanation:</strong></h3>\n<p>BRCA1 (Breast Cancer 1) is a <strong>tumour suppressor gene</strong> located on chromosome 17.</p>\n<ul>\n<li>Mutations in BRCA1 <strong>significantly increase the risk of breast and ovarian cancers</strong>.</li>\n<li>BRCA1-related breast cancers are often:\n<ul>\n<li><strong>Triple-negative</strong>(ER-, PR-, HER2-)</li>\n<li>High-grade invasive ductal carcinomas</li>\n<li>Early onset (&lt;50 years)</li>\n</ul>\n</li>\n<li><strong>Lifetime risk of breast cancer:</strong>~55-65% for BRCA1 mutation carriers.</li>\n</ul>\n<p><strong>Investigations &amp; Management:</strong></p>\n<ul>\n<li><strong>Genetic testing:</strong>BRCA1/2 mutation analysis for high-risk individuals (family history, early-onset breast/ovarian cancer).</li>\n<li><strong>Screening:</strong>Enhanced surveillance with MRI/mammography starting earlier.</li>\n<li><strong>Preventive options:</strong>\n<ul>\n<li>Prophylactic mastectomy or oophorectomy in mutation carriers.</li>\n<li>Lifestyle modifications and chemoprevention (tamoxifen/raloxifene).</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation for other options:</strong></p>\n<p><strong>BRCA 2 (Option B): </strong>Also a tumour suppressor gene on chromosome 13. Increases breast and ovarian cancer risk, but is slightly <strong>less commonly associated with triple-negative tumours</strong> than BRCA1. Lifetime risk of breast cancer: ~45-55%.</p>\n<p><strong>PTEN (Option C): </strong>Tumour suppressor gene; mutations are associated with <strong>Cowden syndrome</strong>, which increases breast cancer risk among other tumours. <strong>Less common</strong> cause of hereditary breast cancer compared to BRCA1/2.</p>\n<p><strong>KRAS (Option D): </strong>Oncogene commonly involved in <strong>colon, lung, and pancreatic cancers</strong>.<br />Rarely implicated in breast cancer.</p>\n<p><strong>Key takeaway:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510043c5c2770-c283-4952-a7b1-96bb068e7aa0.PNG\">\n<p><strong>p53 Mutation and Breast Cancer</strong></p>\n<ul>\n<li><strong>Gene:</strong>TP53, located on chromosome 17p13.1, encodes the <strong>p53 tumour suppressor protein</strong>, often called the \"guardian of the genome.\"</li>\n<li><strong>Function:</strong>p53 regulates <strong>cell cycle arrest, DNA repair, senescence, and apoptosis</strong> in response to DNA damage, preventing propagation of mutated cells.</li>\n<li><strong>Mutation Impact:</strong>\n<ul>\n<li>Loss-of-function or missense mutations in p53 lead to <strong>uncontrolled cell proliferation</strong>and accumulation of genetic errors.</li>\n<li>p53 mutations are associated with <strong>high-grade, aggressive breast cancers</strong>, often with poor prognosis.</li>\n</ul>\n</li>\n<li><strong>Clinical Association:</strong>\n<ul>\n<li>Found in <strong>Li-Fraumeni syndrome</strong>, a rare hereditary disorder causing early-onset breast cancer and multiple other malignancies.</li>\n<li>Sporadic p53 mutations occur in <strong>20-40% of breast cancers</strong>, particularly <strong>triple-negative breast cancers</strong>.</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Triple negative type</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">ER negative type</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">PR positive type</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">HER-2 NEU negative type</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which subtype of breast carcinoma is not known to occur with the BRCA1 mutation?</span></p>",
      "unique_key": "DT1187209",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187209,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>PR positive type</strong> is not known to occur with the BRCA 1 mutation.</p>\n<ul>\n<li><strong>BRCA1-associated tumors</strong> are typically:\n<ul>\n<li>High grade</li>\n<li>Hormone receptor-negative (<strong>ER- and PR-negative</strong>)<strong>(Option B Ruled out )</strong></li>\n<li>HER2-negative <strong>(Option D Ruled out )</strong></li>\n<li><strong>Triple negative</strong> phenotype <strong>(Option A Ruled out )</strong></li>\n<li>Aneuploid, with increased S-phase fraction</li>\n</ul>\n</li>\n<li>These features make them biologically more aggressive and with a less favourable histopathology compared with BRCA2-associated cancers.</li>\n<li><strong>BRCA2-associated tumours</strong>, in contrast, are more often <strong>hormone receptor-positive (ER/PR positive)</strong>.</li>\n</ul>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Proliferative disease without atypia</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical ductal hyperplasia</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical lobular hyperplasia</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Lobular carcinoma in situ</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which histological finding is linked to the lowest relative risk of breast carcinoma?</span></p>",
      "unique_key": "DT1187212",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187212,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Proliferative Disease without Atypia </strong>includes lesions like <strong>usual ductal hyperplasia, sclerosing adenosis, and papillomas without atypia</strong>.</p>\n<ul>\n<li>These are <strong>benign proliferative changes</strong>in the breast epithelium.</li>\n<li><strong>Relative risk (RR) for breast cancer:</strong>~1.5-2&times; higher than the general population, <strong>lowest among the listed options</strong>.</li>\n<li>Often discovered incidentally on biopsy for other lesions.</li>\n</ul>\n<p><strong>Investigations &amp; Management:</strong></p>\n<ul>\n<li><strong>Proliferative disease without atypia:</strong>Usually <strong>no surgical intervention</strong>, routine follow-up and mammography.</li>\n<li><strong>Atypical lesions &amp; LCIS:</strong>Consider <strong>excision, chemoprevention (e.g., tamoxifen), and close surveillance</strong>.</li>\n</ul>\n<p><strong>Explanation for other options:</strong></p>\n<p><strong>Atypical Ductal Hyperplasia (Option B): </strong>Pre-malignant lesion with <strong>abnormal proliferation of ductal epithelial cells with cytologic atypia</strong>. RR for breast cancer: ~4-5&times; higher. Considered a <strong>marker for increased risk</strong> and is sometimes managed with surgical excision.</p>\n<p><strong>Atypical Lobular Hyperplasia (Option C): </strong>Proliferation of <strong>lobular epithelial cells with atypia</strong>. RR: ~4-5&times; higher. Associated with <strong>bilateral risk</strong>; often detected incidentally.</p>\n<p><strong>Lobular Carcinoma in Situ (LCIS) (Option D): </strong>Considered <strong>both a risk marker and a non-invasive neoplasm</strong>. RR: ~8-10&times; higher than the general population. Increases risk in <strong>both breasts</strong>, requiring close surveillance or chemoprevention in some cases.</p>\n<p><strong>Key takeaway:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251004c12260ef-6248-4d12-82df-78babd4fa942.PNG\">",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Highly aggressive tumour</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Presents with painful, swollen breasts with cutaneous oedema</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">It results from the blockage of intramuscular lymphatics with carcinoma cells</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">It mimics a breast abscess</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following statements is false regarding inflammatory breast carcinoma?</span></p>",
      "unique_key": "DT1187218",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187218,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Inflammatory carcinoma is due to the blockage of the subdermal lymphatics with carcinoma cells.</p>\n<ul>\n<li>Rare</li>\n<li><strong>Highly aggressive (Option A ruled out ) </strong></li>\n<li>Presents as a painful, swollen breast, which is warm with cutaneous oedema. <strong>(Option B ruled out )</strong></li>\n<li>Due to the <strong>blockage of the subdermal lymphatics</strong> by carcinoma cells.</li>\n<li>Inflammatory cancer usually involves at least one-third of the breast and <strong>may mimic a breast abscess. (Option D ruled out )</strong></li>\n<li>A <strong>biopsy</strong> will confirm the diagnosis and show undifferentiated carcinoma cells.</li>\n<li>It used to be rapidly fatal, but with aggressive chemotherapy and radiotherapy and with salvage surgery, the prognosis has improved considerably.</li>\n</ul>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Level I axillary lymph nodes</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Level II axillary lymph nodes</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Level III axillary lymph nodes</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Internal mammary lymph nodes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Where does the lymphatic spread occur for a tumour in the posterior one-third of the breast?</span></p>",
      "unique_key": "DT1187223",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187223,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Lymphatic drainage of the breast is not uniform and depends on the <strong>site of the tumour</strong>.</p>\n<ul>\n<li><strong>Anterior 2/3 (superficial and central breast tissue):</strong>Mainly drains to the <strong>axillary lymph nodes</strong> (Level I &rarr; II &rarr; III, depending on extent).</li>\n<li><strong>Posterior 1/3 (deep portion, particularly the medial quadrants and retroareolar region):</strong>Drains predominantly to the <strong>internal mammary lymph nodes</strong> via perforating branches that accompany the internal thoracic vessels.</li>\n</ul>\n<p>This pattern is clinically important because <strong>tumours in the inner quadrants/posterior third</strong> are more likely to metastasise to the internal mammary chain, which is not palpable on clinical exam but detectable on imaging.<br />Involvement of the <strong>supraclavicular nodes</strong> and of any contralateral lymph nodes represents advanced disease.</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Lumbar vertebra</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Femur</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Skull</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Ribs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Breast cancer most commonly metastasises to which part of the skeletal system?</span></p>",
      "unique_key": "DT1187224",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187224,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Skeletal metastases occur via the <strong>bloodstream </strong>in breast carcinoma. The commonly involved sites, in order of frequency, include:</p>\n<ul>\n<li><strong>Lumbar vertebrae - most common</strong></li>\n<li>Femur <strong>(Option B ruled out )</strong></li>\n<li>Thoracic vertebrae</li>\n<li>Ribs <strong>(Option D ruled out )</strong></li>\n<li>Skull <strong>(Option C ruled out )</strong></li>\n</ul>\n<p>The deposits are generally more <strong>osteolytic than osteoblastic</strong>.</p>\n<p>Metastases may also commonly occur in the liver, lungs and brain and, occasionally, the adrenal glands and ovaries via the bloodstream.</p>\n<p><strong>Hematogenous Spread of Breast Carcinoma via Batson's Plexus</strong></p>\n<ul>\n<li><strong>Batson's plexus (vertebral venous plexus)</strong>is a network of valveless veins running along the <strong>entire vertebral column</strong>, connecting the deep pelvic veins and thoracic veins to the internal vertebral venous plexuses.</li>\n<li>Because these veins are <strong>valveless</strong>, blood flow can be bidirectional and influenced by changes in intra-abdominal or intrathoracic pressure (e.g., coughing, straining).</li>\n<li>This unique feature allows <strong>cancer cells from the breast</strong>(and also from pelvic organs like the prostate) to spread directly to the <strong>vertebrae and spinal structures</strong> without first passing through the lungs.</li>\n<li>Hence, <strong>breast carcinoma commonly metastasises to the vertebral column</strong>via Batson's plexus, leading to <strong>bony metastases</strong> and sometimes spinal cord compression.</li>\n</ul>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Peau d'orange</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin tethering</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Eczema of the breast</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin puckering</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most likely diagnosis based on the findings in the given image?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;  \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024031959ff7a9d-26ca-4d39-93ae-70dbe37caa69.jpg\"></span></p>",
      "unique_key": "DT1187229",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187229,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Peau d'orange</strong> (skin of the orange) is seen in breast carcinoma when there is infiltration of the <strong>dermal lymphatics</strong> by malignant cells.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;  \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403194bc6c80f-3680-4dd4-bd1d-c5b140729157.jpg\">\n<p><strong>Explanation of other Options:</strong></p>\n<p><strong>Skin tethering(Option B): </strong>Skin tethering is a clinical sign seen in breast carcinoma, where the skin over the tumour appears pulled in, puckered, or dimpled. It is a visible and/or palpable abnormality that may indicate the infiltration of Cooper's ligaments (suspensory ligaments of the breast) by a malignant tumour.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025100482032a54-e6ac-4455-8f94-8171574bf795.PNG\">\n<p><strong>Eczema of breast(Option C): </strong>Eczema of the breast\" refers to inflammatory skin changes affecting the nipple and/or areola, which can be benign (eczema/dermatitis) or a sign of underlying malignancy such as Paget's disease of the breast.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510047e8f8a28-81ce-40e2-a6a7-c3505db01b78.PNG\">\n<p><strong>Skin puckering(Option D): </strong>Skin puckering is a clinical sign often seen in breast carcinoma, particularly invasive types. It appears as dimpling or wrinkling of the skin overlying the tumour and is an important indicator of potential malignancy.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251004d22bd1c5-72e4-4c07-a114-979ec18cbdb5.PNG\">",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">T2N1aM0</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">T3N1aM0</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">T2N1bM0</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">T3N1bM0</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the TNM stage of breast carcinoma in a patient with a 3 cm breast tumour, metastasis to 2 axillary lymph nodes, and no distant metastasis?</span></p>",
      "unique_key": "DT1187231",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187231,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>TNM stage of breast carcinoma in a patient with a 3 cm breast tumour, metastasis to 2 axillary lymph nodes, and no distant metastasis is <strong>T2N1aM0</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510045a0d685e-7643-40db-b28a-e0bde7148d0c.PNG\"><br>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240401120d5461-9f5c-4917-9baf-de8b517f1c2e.jpg\">",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Mammography</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Ultrasound</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Cytological analysis</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Excisional biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the preferred diagnostic method for phyllodes tumours of the breast?</span></p>",
      "unique_key": "DT1187307",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187307,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Excisional biopsy</strong> followed by careful pathologic review is the best method of diagnosing phyllodes tumours.</p>\n<ul>\n<li>Phyllodes tumours are seen on <strong>mammography</strong> as round densities with smooth borders and are indistinguishable from fibroadenomas.</li>\n<li><strong>Ultrasonography</strong> may reveal a discrete structure with cystic spaces</li>\n<li><strong>Cytological</strong><strong>analysis</strong> is unreliable in differentiating a low-grade phyllodes tumour from a fibroadenoma.</li>\n</ul>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Dubin-Johnson syndrome</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Stewart-Treves syndrome</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Fitz hugs Curtis syndrome</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Ehlers-Danlos syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which condition refers to angiosarcoma developing in the ipsilateral arm as a complication of chronic post-surgical lymphedema?</span></p>",
      "unique_key": "DT1187315",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187315,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Stewart-Treves syndrome</strong> refers to the development of <strong>lymphangiosarcoma (angiosarcoma)</strong> in the <strong>ipsilateral upper limb</strong> following <strong>long-standing chronic lymphedema</strong>.</li>\n<li>It is most often seen after <strong>radical mastectomy with axillary lymph node dissection and radiotherapy</strong> in breast cancer patients.</li>\n<li>The tumour usually appears as <strong>multiple purplish nodules or plaques</strong> on the edematous arm.</li>\n<li>Prognosis is generally <strong>poor</strong>, as angiosarcoma is aggressive and metastasises early.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Dubin-Johnson syndrome (Option A): </strong>A rare inherited benign disorder of bilirubin metabolism. Characterised by <strong>chronic conjugated hyperbilirubinemia</strong> and a <strong>black liver</strong> on gross pathology. Not related to lymphedema or angiosarcoma.</p>\n<p><strong>Fitz-Hugh-Curtis syndrome (Option C): </strong>A complication of <strong>pelvic inflammatory disease (PID)</strong> caused by Chlamydia trachomatis or Neisseria gonorrhoeae. Involves <strong>perihepatic adhesions</strong> (\"violin-string adhesions\") between the liver capsule and abdominal wall.</p>\n<p><strong>Ehlers-Danlos syndrome (Option D): </strong>A group of inherited connective tissue disorders.<br />Presents with <strong>hyperextensible skin, hypermobile joints, and fragile tissues</strong>. No link with post-mastectomy lymphedema or angiosarcoma.</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IIA</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IIB</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IIIA</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IIIB</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the stage of the disease for T2N2M0 for breast carcinoma?</span></p>",
      "unique_key": "DT1187346",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187346,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The stage of the disease for T2N2M0 for breast carcinoma is <strong>Stage IIIA.</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251004e14dba61-5a14-4b2c-8e38-d558226e0229.PNG\">",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">P53 mutation</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe pulmonary disease</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic scleroderma</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following conditions is not considered an absolute contraindication for radiation treatment in breast cancer?</span></p>",
      "unique_key": "DT1187365",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187365,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>All the options given are relative contraindications of radiotherapy in breast cancer.</p>\n<p><strong>Pregnancy is an absolute contraindication.</strong></p>\n<p><strong>Contraindications to Radiation Therapy</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510045d4aaade-a74f-4229-9916-4ef3f6d82538.PNG\">",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Distant metastasis is common</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermal lymph node invasion is common</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythema is confined to the lesion</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Cancer is not sharply delineated</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not a feature of inflammatory breast cancer?</span></p>",
      "unique_key": "DT1187380",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187380,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In <strong>inflammatory breast cancer (IBC)</strong>, erythema is <strong>not confined to a localised lesion</strong> but rather involves <strong>at least one-third of the breast</strong>, giving it a diffuse, inflamed appearance (peau d'orange).</p>\n<p><strong>Key Features of Inflammatory Breast Cancer:</strong></p>\n<ul>\n<li>Rapid onset of breast erythema, swelling, and warmth.</li>\n<li><strong>Peau d'orange appearance</strong> due to dermal lymphatic invasion.</li>\n<li><strong>Distant metastasis is common (option A ruled out ).</strong></li>\n<li><strong>Dermal lymphatic invasion is common</strong><strong>(option B ruled out).</strong><strong><br /></strong></li>\n<li>The cancer is <strong>not sharply delineated</strong> and often infiltrative <strong>(option D ruled out).</strong></li>\n<li>Poor prognosis; aggressive course.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251004f5713b2a-2695-400e-9428-0d48ca09946f.PNG\">",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Lumpectomy</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Tylectomy</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Patey's procedure</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Wide local excision</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not a technique of breast conservation surgery?</span></p>",
      "unique_key": "DT1187398",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187398,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Patey's procedure is a type of mastectomy. It is not a breast-conserving surgery.</p>\n<ul>\n<li>Breast-conserving surgeries include <strong>lumpectomy,</strong>partial mastectomy, segmental mastectomy, segmentectomy, <strong>tylectomy, and wide local excision. (Options A, B &amp; D ruled out)</strong></li>\n<li>Breast-conserving surgery removes the malignancy with a surrounding rim of grossly normal breast parenchyma.</li>\n</ul>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">After 6 months</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">After 2 years</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">After 3 years</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Shouldn't be advised for reconstruction surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What should be the ideal time for reconstruction surgery for breast carcinoma after radiation therapy?</span></p>",
      "unique_key": "DT1187402",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187402,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Reconstruction surgery for breast carcinoma after radiation therapy <strong>is generally not recommended for 1 to 2 years to facilitate healing and recovery.</strong></p>\n<p>In irradiated tissue, there is a higher rate of tissue necrosis, seroma formation, and infection.</p>\n<p>The use of vascularized tissue from outside the radiation field is the favoured approach. If the main deformity is caused by asymmetry with the contralateral breast, a mastopexy of the contralateral breast can be considered.</p>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Breast tissue</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin and nipple areola complex</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Pectoralis major</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Fascia and lymph nodes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following structures is preserved in the patient's mastectomy?</span></p>",
      "unique_key": "DT1187418",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187418,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In Patey's mastectomy, the breast and associated structures are dissected en bloc, and the excised mass is composed of the following:</p>\n<ul>\n<li>Whole breast tissue <strong>(Option A ruled out )</strong></li>\n<li>Skin over the breast tissue<strong>(Option B ruled out )</strong></li>\n<li>Nipple areola complex</li>\n<li>Fat, fascia and lymph nodes of the axilla. <strong>(Option D ruled out )</strong></li>\n</ul>\n<p>The pectoralis minor muscle is either divided or retracted to gain access to the upper two-thirds of the axilla.</p>\n<p>The <strong>axillary vein and nerves to the serratus anterior and latissimus dorsi should be preserved</strong>.</p>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Size of the tumour</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Pathological status of the axillary lymph nodes</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Age of the patient</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Distant metastasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most important prognostic factor in patients with breast carcinoma?</span></p>",
      "unique_key": "DT1187421",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187421,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>presence and number of metastatic axillary lymph nodes</strong> are the single most important prognostic factor in breast cancer.</li>\n<li>It strongly predicts <strong>overall survival</strong>, risk of <strong>recurrence</strong>, and guides the need for <strong>adjuvant therapy</strong>.</li>\n<li>Patients with <strong>node-negative disease</strong> generally have a much better prognosis than those with <strong>node-positive disease</strong>.</li>\n</ul>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Size of the tumour (option A): </strong>Tumour size is an important prognostic factor, as larger tumours (&gt;5 cm) have a higher risk of recurrence and metastasis. However, its prognostic significance is <strong>less than lymph node involvement</strong>.</p>\n<p><strong>Age of the patient (option C): </strong>Younger (&lt;35 years) or older (&gt;70 years) age may influence prognosis slightly due to tumour biology and comorbidities. <strong>Age alone</strong> is not as strong a predictor as nodal status.</p>\n<p><strong>Distant metastasis (option D): </strong>Presence of <strong>distant metastasis (Stage IV)</strong> indicates <strong>poor prognosis</strong>, but this reflects <strong>advanced disease</strong> rather than a predictive factor in early diagnosis. For early-stage breast cancer, nodal involvement is more relevant for prognosis and treatment planning.</p>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Letrozole</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Anastrozole</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Tamoxifen</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Exemestane</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is used in premenopausal women with receptor-positive breast tumour?</span></p>",
      "unique_key": "DT1187423",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187423,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Women with <strong>hormone receptor-positive </strong>(ER+ or PR+) <strong>breast tumours</strong> can be treated with:</p>\n<ul>\n<li>T<strong>amoxifen</strong> in <strong>premenopausal women</strong>. It is a selective estrogen receptor modulator with antagonistic activity at the breast and agonistic activity at the uterus and bone.</li>\n<li><strong>Aromatase inhibitors(AIs)</strong>like anastrozole, letrozole and exemestane in <strong>postmenopausal women</strong>. AIs inhibit aromatase enzymes, which convert androstenedione into estrone. <strong>( Option A, B, D ruled out )</strong></li>\n</ul>",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclophosphamide</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">5- fluorouracil</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Vincristine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not commonly used in a chemotherapy regimen for breast carcinoma patients?</span></p>",
      "unique_key": "DT1187428",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187428,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Vincristine is not used in chemotherapy for breast cancer.</p>\n<ul>\n<li>The most commonly used chemotherapy regimen is the <strong>ACT regimen</strong>[Adriamycin, Cyclophosphamide, Taxane (Paclitaxel)].</li>\n<li>Less commonly used regimen includes <strong>cyclophosphamide, methotrexate and 5-fluorouracil</strong>. <strong>(Option A, B, C ruled out )</strong></li>\n</ul>",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Tamoxifen</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Herceptin</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxorubicin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following agents is used in the HER-2-neu-positive breast carcinoma patient?</span></p>",
      "unique_key": "DT1187431",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187431,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation :</strong></p>\n<p><strong>Herceptin (Trastuzumab)</strong> is a <strong>monoclonal antibody</strong> that specifically targets the <strong>HER-2/neu receptor</strong>, which is overexpressed in some breast cancers. It <strong>inhibits tumour growth</strong> and <strong>improves survival</strong> in HER-2-positive breast cancer patients. Often used <strong>alone or in combination with chemotherapy</strong> for early-stage, locally advanced, or metastatic HER-2-positive breast cancer.</p>\n<p><strong>Explanation for Other Options:</strong></p>\n<p><strong>Methotrexate (option A): </strong>Methotrexate is an <strong>antimetabolite chemotherapeutic</strong> used in various cancers. It is <strong>not specific for HER-2-positive breast cancer</strong> and does not target the HER-2 receptor.</p>\n<p><strong>Tamoxifen (option B): </strong>Tamoxifen is a <strong>selective estrogen receptor modulator (SERM)</strong> used in <strong>ER/PR-positive breast cancer</strong>. It does <strong>not affect the HER-2 receptor</strong>, so it is not the primary treatment for HER-2-positive tumours unless there is co-expression of hormone receptors.</p>\n<p><strong>Doxorubicin (option D): </strong>Doxorubicin is an <strong>anthracycline chemotherapy agent</strong> used in many types of breast cancer. While it can be part of chemotherapy regimens for HER-2-positive breast cancer, it <strong>does not specifically target HER-2</strong>, unlike Herceptin.</p>",
      "correct_choice_id": 223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Peau d'orange</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin dimpling</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphoedema</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Cancer-en-cuirasse</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not a complication of lymphatic obstruction in a patient with breast cancer?</span></p>",
      "unique_key": "DT1187434",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187434,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Skin dimpling</strong> occurs because of traction on Cooper's ligaments by the tumour. Seen best when the arm is abducted overhead.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251004816c797b-02ba-449d-8a7d-e630cf792a5d.PNG\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Peau d'orange (Option A): </strong>Caused by cutaneous lymphatic oedema due to dermal infiltration by malignant cells.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510043913afa8-4f5c-46f6-b383-6144631deb73.PNG\">\n<p><strong>Lymphoedema (Option C):</strong> Neoplastic infiltration of the axilla can cause arm swelling as a result of both lymphatic and venous blockage. It can also occur following radical axillary dissection for tumour removal.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510042aa7d1c9-4654-4dda-9a45-1e3a89eabf50.PNG\">\n<p><strong>Cancer-en-cuirasse (Option D):</strong> The skin of the chest is infiltrated with carcinoma and has been likened to a coat. It may be associated with a grossly swollen arm.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251004d2bfa769-20e5-4157-8ad0-2d33dd494dad.PNG\">",
      "correct_choice_id": 232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Latissimus dorsi flap</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Perforator abdominal flap</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Transverse rectus abdominis flap</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Pectoralis major flap</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following flaps is not used in breast reconstruction surgery?</span></p>",
      "unique_key": "DT1187437",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187437,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The pectoralis major flap is not used in breast reconstruction surgery.</p>\n<p>Autologous tissue reconstruction in breast surgery is done using the following muscle flaps-</p>\n<ul>\n<li><strong>Latissimus dorsi flap</strong>- based on the thoracodorsal pedicle</li>\n<li>Muscle-preserving <strong>perforator abdominal flaps</strong>- Ex: Deep inferior epigastric perforator <strong>(DIEP) flap</strong></li>\n<li><strong>Transverse rectus abdominis myocutaneous (TRAM) flap</strong>- based on superior or inferior epigastric artery or both.</li>\n</ul>",
      "correct_choice_id": 244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Gynaecomastia</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">BRCA 1 mutation</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Exogenous oestrogen</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Klinefelter syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not commonly associated with male breast carcinoma?</span></p>",
      "unique_key": "DT1187439",
      "question_audio": null,
      "question_video": null,
      "map_id": 1187439,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The BRCA1 mutation is not commonly associated with male breast cancer.</p>\n<p>Risk factors for carcinoma of the male breast include:</p>\n<ul>\n<li>Gynaecomastia <strong>(Option A ruled out )</strong></li>\n<li>Excess endogenous or exogenous oestrogen <strong>(Option C ruled out )</strong></li>\n<li><strong>BRCA2</strong> mutation</li>\n<li>Klinefelter syndrome<strong>(Option D ruled out )</strong></li>\n</ul>\n<p><strong>Infiltrating ductal carcinoma</strong> is the most common type of breast cancer in men.</p>\n<p>Diagnosis, grading, treatment and prognosis are the same as female breast cancer.</p>\n<p>The<strong> BRCA2 </strong>mutation mostly causes a<strong> hormone receptor-positive tumour.</strong> Hence, tamoxifen can be used for treatment.</p>",
      "correct_choice_id": 252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}